Literature DB >> 33593972

Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model.

Ericka Kirkpatrick Roubidoux1,2, Juan Manuel Carreño1, Meagan McMahon1, Kaijun Jiang1, Harm van Bakel3,4, Patrick Wilson5, Florian Krammer6.   

Abstract

Current seasonal influenza virus vaccines target regions of the hemagglutinin (HA) head domain that undergo constant antigenic change, forcing the painstaking annual reformulation of vaccines. The development of broadly protective or universal influenza virus vaccines that induce cross-reactive, protective immune responses could circumvent the need to reformulate current seasonal vaccines. Many of these vaccine candidates target the HA stalk domain, which displays epitopes conserved within and across influenza virus subtypes, including those with pandemic potential. While HA head-mediated antigenic drift is well understood, the potential for antigenic drift in the stalk domain is understudied. Using a panel of HA stalk-specific monoclonal antibodies (MAbs), we applied selection pressure to the stalk domain of A/Netherlands/602/2009 (pdmH1N1) to determine fitness and phenotypes of escape mutant viruses (EMVs). We found that HA stalk MAbs with lower cross-reactivity caused single HA stalk escape mutations, whereas MAbs with broader cross-reactivity forced multiple mutations in the HA. Each escape mutant virus greatly decreased mAb neutralizing activity, but escape mutations did not always ablate MAb binding or Fc-Fc receptor-based effector functions. Escape mutant viruses were not attenuated in vitro but showed attenuation in an in vivo mouse model. Importantly, mice vaccinated with a chimeric HA universal vaccine candidate were protected from lethal challenge with EMVs despite these challenge viruses containing escape mutations in the stalk domain. Our study indicates that while the HA stalk domain can mutate under strong MAb selection pressure, mutant viruses may have attenuated phenotypes and do not evade a polyclonal, stalk-based vaccine-induced response.IMPORTANCE Broadly protective or universal influenza virus vaccines target viral epitopes that appear to be conserved. However, it is unclear whether the virus will be able to escape once immunological pressure is applied to these epitopes through vaccination of large proportions of the population. Studies that investigate the fitness and antigenic characteristics of viruses that escape immunological pressure on these conserved epitopes are therefore urgently needed.
Copyright © 2021 Roubidoux et al.

Entities:  

Keywords:  influenza; stalk-based vaccines; universal influenza virus vaccines

Year:  2021        PMID: 33593972     DOI: 10.1128/mBio.03617-20

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


  9 in total

1.  The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade.

Authors:  Shannon R Christensen; Emily T Martin; Joshua G Petrie; Arnold S Monto; Scott E Hensley
Journal:  J Virol       Date:  2022-05-19       Impact factor: 6.549

2.  Genome characterization and mutation analysis of human influenza A virus in Thailand.

Authors:  Somruthai Rattanaburi; Vorthon Sawaswong; Pattaraporn Nimsamer; Oraphan Mayuramart; Pavaret Sivapornnukul; Ariya Khamwut; Prangwalai Chanchaem; Kritsada Kongnomnan; Nungruthai Suntronwong; Yong Poovorawan; Sunchai Payungporn
Journal:  Genomics Inform       Date:  2022-06-30

Review 3.  Defining the risk of SARS-CoV-2 variants on immune protection.

Authors:  Marciela M DeGrace; Elodie Ghedin; Matthew B Frieman; Florian Krammer; Alba Grifoni; Arghavan Alisoltani; Galit Alter; Rama R Amara; Ralph S Baric; Dan H Barouch; Jesse D Bloom; Louis-Marie Bloyet; Gaston Bonenfant; Adrianus C M Boon; Eli A Boritz; Debbie L Bratt; Traci L Bricker; Liliana Brown; William J Buchser; Juan Manuel Carreño; Liel Cohen-Lavi; Tamarand L Darling; Meredith E Davis-Gardner; Bethany L Dearlove; Han Di; Meike Dittmann; Nicole A Doria-Rose; Daniel C Douek; Christian Drosten; Venkata-Viswanadh Edara; Ali Ellebedy; Thomas P Fabrizio; Guido Ferrari; Will M Fischer; William C Florence; Ron A M Fouchier; John Franks; Adolfo García-Sastre; Adam Godzik; Ana Silvia Gonzalez-Reiche; Aubree Gordon; Bart L Haagmans; Peter J Halfmann; David D Ho; Michael R Holbrook; Yaoxing Huang; Sarah L James; Lukasz Jaroszewski; Trushar Jeevan; Robert M Johnson; Terry C Jones; Astha Joshi; Yoshihiro Kawaoka; Lisa Kercher; Marion P G Koopmans; Bette Korber; Eilay Koren; Richard A Koup; Eric B LeGresley; Jacob E Lemieux; Mariel J Liebeskind; Zhuoming Liu; Brandi Livingston; James P Logue; Yang Luo; Adrian B McDermott; Margaret J McElrath; Victoria A Meliopoulos; Vineet D Menachery; David C Montefiori; Barbara Mühlemann; Vincent J Munster; Jenny E Munt; Manoj S Nair; Antonia Netzl; Anna M Niewiadomska; Sijy O'Dell; Andrew Pekosz; Stanley Perlman; Marjorie C Pontelli; Barry Rockx; Morgane Rolland; Paul W Rothlauf; Sinai Sacharen; Richard H Scheuermann; Stephen D Schmidt; Michael Schotsaert; Stacey Schultz-Cherry; Robert A Seder; Mayya Sedova; Alessandro Sette; Reed S Shabman; Xiaoying Shen; Pei-Yong Shi; Maulik Shukla; Viviana Simon; Spencer Stumpf; Nancy J Sullivan; Larissa B Thackray; James Theiler; Paul G Thomas; Sanja Trifkovic; Sina Türeli; Samuel A Turner; Maria A Vakaki; Harm van Bakel; Laura A VanBlargan; Leah R Vincent; Zachary S Wallace; Li Wang; Maple Wang; Pengfei Wang; Wei Wang; Scott C Weaver; Richard J Webby; Carol D Weiss; David E Wentworth; Stuart M Weston; Sean P J Whelan; Bradley M Whitener; Samuel H Wilks; Xuping Xie; Baoling Ying; Hyejin Yoon; Bin Zhou; Tomer Hertz; Derek J Smith; Michael S Diamond; Diane J Post; Mehul S Suthar
Journal:  Nature       Date:  2022-03-31       Impact factor: 69.504

Review 4.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

5.  Identifying vaccine escape sites via statistical comparisons of short-term molecular dynamics.

Authors:  Madhusudan Rajendran; Maureen C Ferran; Gregory A Babbitt
Journal:  Biophys Rep (N Y)       Date:  2022-04-04

6.  Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.

Authors:  Ericka Kirkpatrick Roubidoux; Kaori Sano; Meagan McMahon; Juan Manuel Carreño; Christina Capuano; Kaijun Jiang; Viviana Simon; Harm van Bakel; Patrick Wilson; Florian Krammer
Journal:  J Virol       Date:  2022-04-21       Impact factor: 6.549

Review 7.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

Review 8.  The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations.

Authors:  Kristin B Wiggins; Maria A Smith; Stacey Schultz-Cherry
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

9.  Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses.

Authors:  Osamu Kotani; Yasushi Suzuki; Shinji Saito; Akira Ainai; Akira Ueno; Takuya Hemmi; Kaori Sano; Koshiro Tabata; Masaru Yokoyama; Tadaki Suzuki; Hideki Hasegawa; Hironori Sato
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.